title: Thiopurine methyltransferase (TPMT) genotyping to predict myelosuppression risk.
abstract: Azathioprine (AZA), 6-mercaptopurine (6-MP), and thioguanine (TG) are thiopurine drugs. These agents are indicated for the treatment of various diseases including hematologic malignancies, inflammatory bowel disease (IBD), rheumatoid arthritis, and as immunosuppressants in solid organ transplants. Thiopurine drugs are metabolized, in part, by thiopurine methyltransferase (TPMT). TPMT displays genetic polymorphism resulting in null or decreased enzyme activity. At least 20 polymorphisms have been identified, of which, TPMT *2, *3A, *3B, *3C, and *4 are the most commonly studied. These polymorphisms have been associated with increased myelosuppression risk. TPMT genotyping may be useful to predict this risk.
authors: VA San Diego Healthcare System and UCSD Skaggs School of Pharmacy and Pharmaceutical Sciences.
authors: Christine M
authors: CM
authors: Nguyen
authors: Margaret A S
authors: MA
authors: Mendes
authors: Joseph D
authors: JD
authors: Ma
references: Pharmacogenetics. 2002 Apr;12(3):191-5
references: 11927834
references: J Clin Pathol. 2010 Apr;63(4):288-95
references: 20354201
references: Aliment Pharmacol Ther. 2008 Oct 15;28(8):973-83
references: 18616518
references: Gut. 1995 Feb;36(2):311-3
references: 7883236
references: Intern Med J. 2005 Oct;35(10):580-5
references: 16207256
references: Clin Gastroenterol Hepatol. 2009 Nov;7(11):1195-201; quiz 1141-2
references: 19631285
references: J Clin Gastroenterol. 2002 Sep;35(3):240-4
references: 12192200
references: Am J Gastroenterol. 2000 Sep;95(9):2313-7
references: 11007234
references: Pharmacogenetics. 2002 Aug;12(6):429-36
references: 12172211
references: Ther Drug Monit. 2005 Aug;27(4):435-41
references: 16044099
references: Neuro Endocrinol Lett. 2009;30 Suppl 1:137-42
references: 20027160
references: Best Pract Res Clin Gastroenterol. 2004 Jun;18(3):597-609
references: 15157830
references: Gut. 1993 Aug;34(8):1081-5
references: 8174958
references: J Gastroenterol Hepatol. 2009 Jul;24(7):1258-64
references: 19682195
references: Eur J Hum Genet. 2009 Aug;17(8):991-8
references: 19223932
references: Clin Ther. 2009 Jul;31(7):1524-33
references: 19695401
references: Intern Med J. 2009 Feb;39(2):121-6
references: 19356188
references: Clin Pharmacol Ther. 2011 May;89(5):662-73
references: 21412232
references: Intern Med. 2009;48(9):693-5
references: 19420815
references: Ther Drug Monit. 2011 Apr;33(2):192-9
references: 21240057
references: Aliment Pharmacol Ther. 2007 May 1;25(9):1069-77
references: 17439508
references: Am J Gastroenterol. 2005 Oct;100(10):2239-47
references: 16181376
references: Clin Pharmacol Ther. 2011 Mar;89(3):387-91
references: 21270794
references: Am J Gastroenterol. 2010 Mar;105(3):501-23; quiz 524
references: 20068560
references: Gut. 2004 Sep;53 Suppl 5:V1-16
references: 15306569
references: Evid Rep Technol Assess (Full Rep). 2010 Dec;(196):1-282
references: 23126559
references: Ann Intern Med. 1989 Oct 15;111(8):641-9
references: 2802419
references: Lancet. 1993 Feb 13;341(8842):436
references: 8094196
references: Gastroenterology. 2000 Jun;118(6):1025-30
references: 10833476
references: Dig Liver Dis. 2005 Apr;37(4):282-97
references: 15788214
references: Eur J Gastroenterol Hepatol. 2001 Sep;13(9):1073-6
references: 11564958